Ізраїль - іврит - Ministry of Health

teva pharmaceutical indust.ltd - nitrazepam 5 mg - tablets - nitrazepam - insomnia of various etiology.

Ізраїль - іврит - Ministry of Health

teva pharmaceutical industries ltd, israel - flunitrazepam - טבליה - flunitrazepam 2 mg - flunitrazepam - flunitrazepam - insomnia of various etiology.

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 1 mg/ml - midazolam - midazolam - premedication before induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration). status epilepticus.

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 5 mg/ml - midazolam - midazolam - premedication befor induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration).status epilepticus.

Ізраїль - іврит - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 2.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Ізраїль - іврит - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Ізраїль - іврит - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 7.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Ізраїль - іврит - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride 10 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available

Ізраїль - іврит - Ministry of Health

teva pharmaceutical indust.ltd - brotizolam 0.25 mg - tablets - brotizolam - for the treatment of insomnia.

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - brotizolam - טבליה - brotizolam 0.25 mg - brotizolam - brotizolam - treatment of insomnia.